Skip to main content

Medicines and Healthcare Products Regulatory Agency

Volume 691: debated on Monday 30 April 2007

asked Her Majesty's Government:

What revenue is gained by the Medicines and Healthcare Products Regulatory Agency from interest gained on fees paid by pharmaceutical companies and held by the agency pending (a) assessment work being completed, and (b) refunds of fees made to applicants. [HL3150]

As Medicines and Healthcare Products Regulatory Agency (MHRA) funds from all its various sources of revenue are co-mingled and used to cover all its expenditures, it is not possible to identify which funds earning interest come from fees paid by pharmaceutical companies and held by the agency pending assessment work being completed and refunds of fees made to applicants.

The most recent published accounts for the MHRA show that in 2005-06 the agency received £463,000 in interest that year.